Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Cullen
FOU | Founder | 78 | 21/11/21 |
Jennifer Simpson
CEO | Chief Executive Officer | 55 | 16/20/16 |
Susan Horvath
DFI | Director of Finance/CFO | 65 | 17/18/17 |
Tammy Groene
COO | Chief Operating Officer | - | 01/12/01 |
Chief Tech/Sci/R&D Officer | - | 01/22/01 | |
Rachel Bragg
PRN | Corporate Officer/Principal | - | 01/21/01 |
- | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jennifer Simpson
CEO | Chief Executive Officer | 55 | 16/20/16 |
Director/Board Member | 63 | 30/15/30 | |
Michael Cullen
FOU | Founder | 78 | 21/11/21 |
Jeffrey Jacob
BRD | Director/Board Member | 62 | 15/22/15 |
Arthur Fratamico
BRD | Director/Board Member | 58 | 16/19/16 |
Dan Donovan
BRD | Director/Board Member | 59 | 15/22/15 |
Donald Schemel
BRD | Director/Board Member | 68 | 04/15/04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,854,931 | 4,854,791 ( 100.00 %) | 70 ( 0.001442 %) | 100.00 % |
Company contact information
Panbela Therapeutics, Inc.
712 Vista Boulevard Suite 305
55387, Waconia
+952 479 1196
http://www.panbela.com1st Jan change | Capi. | |
---|---|---|
+13.69% | 3,161B | |
+10.35% | 87.62B | |
+6.56% | 79.59B | |
-13.12% | 54.14B | |
+23.98% | 48.15B | |
+32.73% | 47.69B | |
-25.07% | 46.81B | |
+80.17% | 42B | |
-5.68% | 25.77B |